Tecvayli and Elrexfio have both been cleared for use in patients who have previously ... the company’s only cancer drug is PD-1 inhibitor Libtayo (cemiplimab), approved for squamous cell ...

Patients with a rare disease called mucous membrane pemphigoid are at risk of developing squamous cell carcinoma and basal cell carcinoma, finds a new study.